Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study.

Pelzer F, Tröger W, Nat DR.

J Altern Complement Med. 2018 Sep/Oct;24(9-10):954-961. doi: 10.1089/acm.2018.0159.

2.

Safety of intravenously applied mistletoe extract - results from a phase I dose escalation study in patients with advanced cancer.

Huber R, Schlodder D, Effertz C, Rieger S, Tröger W.

BMC Complement Altern Med. 2017 Sep 18;17(1):465. doi: 10.1186/s12906-017-1971-1.

3.

Ion exchanger in the brain: Quantitative analysis of perineuronally fixed anionic binding sites suggests diffusion barriers with ion sorting properties.

Morawski M, Reinert T, Meyer-Klaucke W, Wagner FE, Tröger W, Reinert A, Jäger C, Brückner G, Arendt T.

Sci Rep. 2015 Dec 1;5:16471. doi: 10.1038/srep16471.

4.

In reply.

Tröger W.

Dtsch Arztebl Int. 2015 Jan 5;112(1-2):11-3. doi: 10.3238/arztebl.2015.0011b. No abstract available.

5.

Quality of life of patients with advanced pancreatic cancer during treatment with mistletoe: a randomized controlled trial.

Tröger W, Galun D, Reif M, Schumann A, Stanković N, Milićević M.

Dtsch Arztebl Int. 2014 Jul 21;111(29-30):493-502, 33 p following 502. doi: 10.3238/arztebl.2014.0493.

6.

Overview of the Publications From the Anthroposophic Medicine Outcomes Study (AMOS): A Whole System Evaluation Study.

Hamre HJ, Kiene H, Ziegler R, Tröger W, Meinecke C, Schnürer C, Vögler H, Glockmann A, Kienle GS.

Glob Adv Health Med. 2014 Jan;3(1):54-70. doi: 10.7453/gahmj.2013.010. Review.

7.

Additional Therapy with a Mistletoe Product during Adjuvant Chemotherapy of Breast Cancer Patients Improves Quality of Life: An Open Randomized Clinical Pilot Trial.

Tröger W, Zdrale Z, Tišma N, Matijašević M.

Evid Based Complement Alternat Med. 2014;2014:430518. doi: 10.1155/2014/430518. Epub 2014 Feb 20.

8.

Viscum album [L.] extract therapy in patients with locally advanced or metastatic pancreatic cancer: a randomised clinical trial on overall survival.

Tröger W, Galun D, Reif M, Schumann A, Stanković N, Milićević M.

Eur J Cancer. 2013 Dec;49(18):3788-97. doi: 10.1016/j.ejca.2013.06.043. Epub 2013 Jul 24.

9.

Five-year follow-up of patients with early stage breast cancer after a randomized study comparing additional treatment with viscum album (L.) extract to chemotherapy alone.

Tröger W, Zdrale Z, Stanković N, Matijašević M.

Breast Cancer (Auckl). 2012;6:173-80. doi: 10.4137/BCBCR.S10558. Epub 2012 Oct 30.

10.

Pulpa dentis D30 for acute reversible pulpitis: A prospective cohort study in routine dental practice.

Hamre HJ, Mittag I, Glockmann A, Kiene H, Tröger W.

Altern Ther Health Med. 2011 Jan-Feb;17(1):16-21.

PMID:
21614940
11.
12.

Local reactions to treatments with Viscum album L. extracts and their association with T-lymphocyte subsets and quality of life.

Büssing A, Tröger W, Stumpf C, Schietzel M.

Anticancer Res. 2008 May-Jun;28(3B):1893-7.

13.

Assessing the order of magnitude of outcomes in single-arm cohorts through systematic comparison with corresponding cohorts: an example from the AMOS study.

Hamre HJ, Glockmann A, Tröger W, Kienle GS, Kiene H.

BMC Med Res Methodol. 2008 Mar 19;8:11. doi: 10.1186/1471-2288-8-11. Review.

14.

Course of mitogen-stimulated T lymphocytes in cancer patients treated with Viscum album extracts.

Büssing A, Stumpf C, Tröger W, Schietzel M.

Anticancer Res. 2007 Jul-Aug;27(4C):2903-10.

15.

Mistletoe extract reduces the surgical suppression of natural killer cell activity in cancer patients. a randomized phase III trial.

Schink M, Tröger W, Dabidian A, Goyert A, Scheuerecker H, Meyer J, Fischer IU, Glaser F.

Forsch Komplementmed. 2007 Feb;14(1):9-17. Epub 2007 Mar 6.

PMID:
17341882
16.

Use and safety of anthroposophic medications in chronic disease: a 2-year prospective analysis.

Hamre HJ, Witt CM, Glockmann A, Tröger W, Willich SN, Kiene H.

Drug Saf. 2006;29(12):1173-89.

PMID:
17147463
17.

[Correlation of NK cell activity against autologous tumour cells and K562 cells with the clinical outcome during therapy with mistletoe extracts].

Schink M, Tröger W, Goyert A, Scheuerecker H, Selbmann HK, Glaser F.

Forsch Komplementmed. 2006 Jun;13(3):147-55. Epub 2006 Jun 26. German.

PMID:
16868360
18.

Zinc- and iron-dependent cytosolic metallo-beta-lactamase domain proteins exhibit similar zinc-binding affinities, independent of an atypical glutamate at the metal-binding site.

Schilling O, Vogel A, Kostelecky B, Natal da Luz H, Spemann D, Späth B, Marchfelder A, Tröger W, Meyer-Klaucke W.

Biochem J. 2005 Jan 1;385(Pt 1):145-53.

19.

[Retrospective study of malignant melanoma patients treated with mistletoe extracts].

Stumpf C, Rosenberger A, Rieger S, Tröger W, Schietzel M, Stein GM.

Forsch Komplementarmed Klass Naturheilkd. 2003 Oct;10(5):248-55. German.

PMID:
14605481
20.

[Childhood diseases, infectious diseases, and fever as potential risk factors for cancer?].

Hoffmann C, Rosenberger A, Tröger W, Bühring M.

Forsch Komplementarmed Klass Naturheilkd. 2002 Dec;9(6):324-30; discussion 323. German.

PMID:
12618549

Supplemental Content

Loading ...
Support Center